Pre-CAAP Company: VivaVax Wins Vinetta Project Finals

Ontario Industry Updates
Written By Guest User

VivaVax is an early-stage life sciences company creating biosafe formulations to protect sensitive medicines from heat fluctuations during transport.

Last week they won the Vinetta Project Finals, which includes a cash prize of $15K, and $25K in legal support from Blakes.

Read about the Vinetta Project here

 

Guest User
Previous

Pre-CAAP Company: Tieos Pharmaceuticals Makes it to Finals of the 2017 BioInnovation Challenge
Next

CAAP Company: Komodo OpenLab Wins 1st Place at the 2017 Interface Health Challenge!